Portfolio
A
BioTech ACTIVE · SERIES E

Alto Pharmacy

AI-powered digital pharmacy

Alto Pharmacy Platform

Status
Active
Nahkoda Round
Series A
Current Stage
Series E
Sector
HealthTech · AI/ML

Alto Pharmacy is revolutionizing the pharmacy experience by building a genuinely patient-centric, technology-driven platform. Their AI-powered software streamlines communication between physicians, insurance providers, and patients — while their courier network delivers reliable, same-day prescription fulfillment.

We invested in Alto because of three compounding factors: an exceptional founding team with deep healthcare operational experience, impressive revenue velocity, and a clear vision to build the operating system for modern healthcare delivery.

Why We Backed Alto at Series A

  • Demonstrated product-market fit with NPS scores consistently above 80
  • Proprietary AI models trained on millions of prescription data points
  • Vertical integration of pharmacy + logistics creates a durable moat
  • Huge TAM: $500B+ US pharmacy market largely untouched by technology

By vertically integrating pharmacy services with modern logistics and a powerful AI backend, Alto is positioned to capture a significant share of a market that has seen almost no technology disruption in decades. The patient experience they deliver is not incrementally better — it is categorically different.

Founded
2015
Headquarters
San Francisco, CA
Total Raised
$354M+
Website
alto.com

More from the portfolio

View All